A detailed history of Caitlin John, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Caitlin John, LLC holds 3 shares of DGX stock, worth $411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 7 57.14%
Holding current value
$411
Previous $984,000 47.97%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $548 - $548
-4 Reduced 57.14%
3 $512,000
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $844 - $987
7 New
7 $984,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Caitlin John, LLC Portfolio

Follow Caitlin John, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitlin John, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caitlin John, LLC with notifications on news.